4 Biotech Startups Developing Breakthrough Drug Modalities
In the dynamic world of drug discovery, companies must continually innovate beyond their existing drug portfolios and modalities. Relying solely …
Biopharma Insights
The Growing Impact of AI in Healthcare
The advent of artificial intelligence (AI) in healthcare has catalyzed an epoch of change, reshaping diagnostic procedures, therapeutic strategies, and …
From Diagnosis to Treatment: The Impact of AI on Rare Disease Drug Development
Drug development for rare (also referred to as orphan) diseases is notoriously challenging. Legislative initiatives, such as the 1983 US …
Optimising Drug Discovery R&D with Graphs
Data in Life Sciences expert Dr Alexander Jarasch on a new wave of advanced data handling techniques that point the …
How Industry Embraces Organ-on-Chips: A 2024 Status Report
Report highlights: We are currently at an exciting juncture where several big pharmaceutical companies have started adopting such models and …
How AI Empowers Biomarker-Driven Clinical Trials
Clinical trials are the lifeline of modern medicine, bridging the gap between lab-borne scientific discoveries and the availability of life-saving …
Patented AI Platform Identifies Promising Early-Stage BioPharma Assets and Companies
Fierce competition. Thin pipelines. Patent cliffs. The stakes are sky-high for pharmaceutical companies and investors alike. With biotech firms often …
Navigating the Brain-Computer Interface Frontier: An Interview with ex-NASA Expert
In a detailed interview, Dr. Brian Jamieson, founder and CTO of Diagnostic Biochips (DBC), delves into the evolving landscape of …
It’s Been a Decade of AI in the Drug Discovery Race. What’s Next?
The year 2012 is often regarded as the beginning of the deep learning revolution. That year, Alexnet, the deep learning …
NVIDIA Introduces New Software Tools for Biopharma AI Applications
NVIDIA's CEO, Jensen Huang, recently outlined the company's expanded focus on software solutions designed to facilitate the adoption of artificial …
Notable Trends and Companies to Follow in Neuroscience
Historically, the approval rate for medicines treating central nervous system (CNS) disorders was low. By 2022, the success rate for …
11 Biopharma Trends to Watch in 2024
2023 has marked a remarkable year of technological advancements in drug discovery and biotechnology. Ironically, the elation from a kaleidoscope …